EHS
EHS

STAT Plus: ‘Stuff floating’ in compounded drugs prompts FDA to appeal for more funding

WASHINGTON — The Food and Drug Administration doesn’t have enough funding or staff to properly regulate pharmaceutical compounders, a top agency official said Friday, describing inspections that turned up “stuff floating around” in supposedly sterile shipments.

The program doesn’t “have adequate core staffing,” said Janet Woodcock, director of the Center for Drug Evaluation and Research, on Friday, adding that it’s one of the center’s programs that is “suffering the most.”

Continue to STAT Plus to read the full story…

Source link

EHS
Back to top button